Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
Endocrine-Related Cancer|October 28, 2020
Epigenetic and metabolic reprogramming of SDH-deficient paragangliomasSophie Moog, Charlotte Lussey-Lepoutre, Judith FavierEndocrine-Related Cancer|March 29, 2022
Preclinical evaluation of targeted therapies in Sdhb-mutated tumorsSophie Moog, Betty Salgues, Yasmine Braik-Djellas, et al.Cell Reports|April 3, 2020
TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal TransitionAurélie Morin, Judith Goncalves, Sophie Moog, et al.Endocrine-Related Cancer|February 22, 2023
Progress and challenges in experimental models for pheochromocytoma and paragangliomaArthur S Tischler, Judith FavierMedecine Sciences : M/S|July 19, 2012
[Genetics of paragangliomas and pheochromocytomas]Judith Favier, Anne-Paule Gimenez-RoqueploAnnales D'Endocrinologie|May 8, 2025
Altitude and paragangliomaJulie Sanceau, Rebecca Westbrook, Judith FavierBest Practice & Research. Clinical Endocrinology & Metabolism|December 1, 2010
Pheochromocytomas: the (pseudo)-hypoxia hypothesisJudith Favier, Anne-Paule Gimenez-RoqueploJournal of Cellular Biochemistry|February 16, 2006
Role of MSK1 in the signaling pathway leading to VEGF-mediated PAF synthesis in endothelial cellsCatherine Marchand, Judith Favier, Martin G SiroisAnnales De Pathologie|March 9, 2020
[Pathologist contribution in the diagnosis of hereditary predisposition to paranganglioma and pheochromocytoma]Chloé Broudin, Judith Favier, Virginie Verkarre, et al.Pageof 14